News
Shortening all-oral HCV therapy feasible
Key clinical point: Shortening HCV therapy to 6-8 weeks is possible, even in cirrhotic patients. Major finding: SVR12 was achieved by 87%-94% of...
News
Anti-CarP antibodies linked to worse outcome in early arthritis
Key clinical point: Anti-CarP antibodies may provide additional prognostic information to current antibody tests in early inflammatory arthritis....
News
BSR: Subclinical synovitis common in RA remission
Key clinical point: Patients with RA in clinical remission defined via clinical criteria alone may still have subclinical inflammation. Major...
News
Ultrasound sign could help diagnose giant cell arteritis
Key clinical point: The halo sign on ultrasound is a diagnostic and potentially prognostic marker, but its use is limited by the effect of early...
News
Add vitamin E to NASH ‘toolkit’
Key clinical point: Vitamin E was shown to improve nonalcoholic steatohepatitis (NASH) to an extent similar to those of pioglitazone, metformin,...
News
Synovial pathotype could help guide anti-TNF therapy
Key clinical point: Early data suggest that synovial tissue analysis may be a potential tool to guide anti-TNF therapy, although more data are...
News
BSR: Patient selection key to using rituximab in lupus
Key clinical point: Although the majority of patients benefited from rituximab, a significant proportion did not, highlighting the need to...
News
BSR: Lengthy SLE remission is possible, late relapses occur
Key clinical point: Patients with systemic lupus erythematosus can achieve complete remission for many years, but relapse can occur decades later...
News
HCV Treatment Delays Dented Efficacy in Era Before All-oral Therapy
Key clinical point: Efficacy diminishes when HCV treatment is delayed, particularly in patients who progress to advanced cirrhosis. Major finding...
News
ILC: HCV treatment delays dented efficacy in era before all-oral therapy
Key clinical point: Efficacy diminishes when HCV treatment is delayed, particularly in patients who progress to advanced cirrhosis. Major finding...
News
ILC: Real-world success for all-oral antiviral therapy in HCV-related cirrhosis
Key clinical point: An all-oral antiviral regimen appears effective and safe for most patients with decompensated cirrhosis due to chronic HCV...
News
EASL: Study supports HCC screening in alcoholic liver disease
Key clinical point: A high rate of hepatic focal lesions suggests that about 10% of patients per year may need a recall diagnosis procedure.
News
Consider HCV a "Cardiovascular Risk Factor"
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor. Major finding: Adjusted...
News
Consider HCV ‘a cardiovascular risk factor’
Key clinical point: Chronic HCV infection was strongly linked to CV outcome and needs to be considered a CV risk factor. Major finding: Adjusted...
News
EASL: Mortality and CV burden increase with NAFLD severity
Key clinical point: Mortality and the prevalence of cardiovascular disease increase across the spectrum of nonalcoholic fatty liver disease (NAFLD...